| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | ibandronic acid (Bonviva®) |
| Formulation | 3 mg solution for injection |
| Reference number | 51 |
| Indication | Treatment of osteoporosis in postmenopausal women |
| Company | Roche Products Ltd/GlaxoSmithKline |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 16/06/2006 |